(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-22 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 261600
| Date | Daily Closing Price | Open | High | Low | Volume |
| 22 Wed Oct 2025 | 14.00 | 14.00 | 14.04 | 13.73 | 0.839 times |
| 21 Tue Oct 2025 | 14.01 | 14.21 | 14.27 | 13.84 | 0.683 times |
| 20 Mon Oct 2025 | 14.31 | 14.35 | 14.41 | 14.05 | 0.832 times |
| 17 Fri Oct 2025 | 14.26 | 14.00 | 14.34 | 13.96 | 1.269 times |
| 16 Thu Oct 2025 | 14.04 | 13.99 | 14.15 | 13.85 | 1.202 times |
| 15 Wed Oct 2025 | 13.90 | 13.85 | 14.59 | 13.50 | 0.758 times |
| 14 Tue Oct 2025 | 13.85 | 14.00 | 14.28 | 13.82 | 1.122 times |
| 13 Mon Oct 2025 | 13.92 | 14.02 | 14.10 | 13.75 | 1.427 times |
| 10 Fri Oct 2025 | 13.99 | 14.44 | 14.44 | 13.85 | 0.904 times |
| 09 Thu Oct 2025 | 14.51 | 14.44 | 14.62 | 14.20 | 0.77 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 13.9 as stoploss in an intra day buy trade for a target of 14.2. However, stock will show a bearish move below 13.9.
Share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Target | 9.98 |
| Downside Target | 10.87 |
| Downside Target | 11.82 |
| Downside Target | 13.47 |
| Upside Target | 14.30 |
| Upside Target | 14.39 |
| Upside Target | 14.41 |
| Upside Target | 14.59 |
| Upside Target | 14.87 |
| Upside Target | 15.15 |
Intraday share price targets for Theravance Biopharma (TBPH)
| Target Type | Value |
| Downside Intraday Target | 13.68 |
| Downside Intraday Target | 13.37 |
| Upside Intraday Target | 14.36 |
| Upside Intraday Target | 14.73 |
| Upside Intraday Target | 14.05 |
Weekly technical analysis of Theravance Biopharma (TBPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 22 Wed Oct 2025 | 14.00 | 14.35 | 14.41 | 13.73 | 0.407 times |
| 17 Fri Oct 2025 | 14.26 | 14.02 | 14.59 | 13.50 | 0.911 times |
| 10 Fri Oct 2025 | 13.99 | 14.80 | 15.15 | 13.85 | 1.071 times |
| 03 Fri Oct 2025 | 14.41 | 14.15 | 14.87 | 13.97 | 1.117 times |
| 26 Fri Sep 2025 | 14.07 | 13.93 | 14.39 | 13.65 | 0.657 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 22 Wed Oct 2025 | 14.00 | 14.49 | 15.15 | 13.50 | 0.48 times |
| 30 Tue Sep 2025 | 14.60 | 13.89 | 14.87 | 13.47 | 0.886 times |
| 29 Fri Aug 2025 | 13.88 | 11.06 | 14.30 | 10.88 | 3.132 times |
| 31 Thu Jul 2025 | 11.16 | 11.00 | 11.88 | 10.87 | 0.478 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.07 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.07 and Theravance Biopharma (TBPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

